EPC insider Form 4 shows PSE vesting and new 15,445 RSE grant

Rhea-AI Filing Summary

Edgewell Personal Care Company (EPC) Chief Supply Chain Officer reported multiple equity award events. On November 13, 2025, 5,773 Performance Stock Equivalents (PSEs) converted into the same number of EPC common shares after performance conditions were met, while 10,580 PSEs were canceled for not meeting those conditions. Shares totaling 2,676 and 1,924 were withheld at $18.39 per share to cover tax liabilities on vesting. A separate award of 4,149 PSEs had its performance conditions satisfied on November 6, 2025 and time vesting completed on November 13, 2025. In addition, the officer received 15,445 Restricted Stock Equivalents (RSEs) on November 14, 2025, each convertible into one share of EPC common stock, vesting in three equal annual installments. Following these transactions, the officer beneficially owned about 48,564.693 shares of EPC common stock directly.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Hibbert Paul

(Last) (First) (Middle)

C/O EDGEWELL PERSONAL CARE COMPANY

6 RESEARCH DRIVE

(Street)

SHELTON CT 06484

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
EDGEWELL PERSONAL CARE Co [ EPC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Supply Chain Officer

3. Date of Earliest Transaction (Month/Day/Year)
11/06/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	11/13/2025		M(1)		5,773	A	$0	49,015.693	D
Common Stock	11/13/2025		F		2,676(2)	D	$18.39	46,399.693	D
Common Stock	11/13/2025		M(3)		4,149	A	$0	50,488.693	D
Common Stock	11/13/2025		F		1,924(2)	D	$18.39	48,564.693	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Performance Stock Equivalents 11-11-2022	$0	11/13/2025		M			5,773	11/13/2025(1)	(1)	Common Stock	5,773	$0	0	D
Performance Stock Equivalents 11-8-2024	$0	11/06/2025		A		4,149		11/13/2025(3)	(3)	Common Stock	4,149	$0	4,149	D
Performance Stock Equialents 11-8-2024	$0	11/13/2025		M			4,149	11/13/2025(3)	(3)	Common Stock	4,149	$0	0	D
Restricted Stock Equivalents 11-14-2025	$0	11/14/2025		A		15,445		11/14/2026(4)	(4)	Common Stock	15,445	$0	15,445	D

Explanation of Responses:

1. Each Performance Stock Equivalent ("PSE") is convertible into one share of common stock of Edgewell Personal Care Company ("EPC"). The performance conditions with respect to 5,773 PSEs were satisfied and vested into EPC common stock on November 13, 2025. The remaining 10,580 PSEs did not satisfy the necessary performance conditions and were canceled on the same date.

2. Reflects shares withheld as payment of a tax liability upon vesting of PSEs.

3. Reflects an award of PSEs for which the performance conditions were satisfied on November 6, 2025 and remaining time vesting conditions were satisfied on November 13, 2025. Each PSE is convertible into shares of EPC common stock.

4. Each Restricted Stock Equivalent ("RSE") is convertible into one share of EPC common stock. The award of RSEs shall vest as to one-third of the original grant of 15,445 RSEs on each of the first three anniversaries of the grant date.

	/s/ Paul Hibbert	11/18/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did EPC report on this Form 4?

The Form 4 reports that Edgewell Personal Care Company’s Chief Supply Chain Officer had multiple equity award events, including the vesting and cancellation of Performance Stock Equivalents (PSEs), tax-withholding share disposals, and a new grant of Restricted Stock Equivalents (RSEs).

How many Performance Stock Equivalents vested for the EPC officer?

5,773 Performance Stock Equivalents (PSEs) converted into the same number of EPC common shares on November 13, 2025 after performance conditions were satisfied.

How many Performance Stock Equivalents were canceled in the EPC Form 4 filing?

The explanation states that 10,580 PSEs did not satisfy the necessary performance conditions and were canceled on November 13, 2025.

What new equity awards did the EPC officer receive?

The officer received an award of 4,149 Performance Stock Equivalents (with performance conditions satisfied on November 6, 2025 and time vesting on November 13, 2025) and a new grant of 15,445 Restricted Stock Equivalents (RSEs) on November 14, 2025.

How do the Restricted Stock Equivalents for EPC vest?

Each Restricted Stock Equivalent (RSE) is convertible into one share of EPC common stock. The 15,445 RSEs vest in three equal parts, with one-third vesting on each of the first three anniversaries of the November 14, 2025 grant date.

Why were some EPC shares reported as disposed of at $18.39?

The filing notes that 2,676 and 1,924 EPC shares were withheld and disposed of at a price of $18.39 per share to satisfy tax liabilities arising from the vesting of Performance Stock Equivalents.

How many EPC common shares does the officer own after these transactions?

After the reported transactions, the officer beneficially owned approximately 48,564.693 shares of EPC common stock directly.